RT Journal Article
SR Electronic
T1 Health-related quality of life in Long COVID: Mapping the condition-specific C19-YRSm measure onto the EQ-5D-5L
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.11.24311809
DO 10.1101/2024.08.11.24311809
A1 Smith, Adam B.
A1 Greenwood, Darren C.
A1 Williams, Paul
A1 Kwon, Joseph
A1 Petrou, Stavros
A1 Horton, Mike
A1 Osborne, Thomas
A1 Milne, Ruairidh
A1 LOCOMOTION Consortium
A1 Sivan, Manoj
YR 2024
UL http://medrxiv.org/content/early/2024/08/12/2024.08.11.24311809.abstract
AB Background Long Covid (LC) is a clinical syndrome of persistent, fluctuating symptoms subsequent to COVID-19 infection with a prevalence global estimate of many millions of cases. LC has significant detrimental effects on health-related quality of life (HRQoL), activities of daily living (ADL), and work productivity. Condition-specific patient-reported outcome measures (PROMs), such as the modified Covid-19 Yorkshire Rehabilitation Scale (C19-YRSm), have been developed to capture the impact of LC. However, these do not provide health utility data required for cost-utility analyses of LC interventions. The aim of this study was therefore to derive a mapping algorithm for the C19-YRSm to enable health utilities to be generated from this PROM.Methods Data were collected from a large study evaluating LC services in the UK. A total of 1434 people with LC had completed both the C19-YRSm and the EQ-5D-5L on the same day. The EQ-5D-5L responses were then converted to EQ-5D-3L utility scores. Correlation and linear regression analyses were applied to determine items from the C19-YRSm and covariates for inclusion in the algorithm. Model fit, mean differences across the range of EQ-5D-3L scores (−0.59 to 1), and Bland-Altman plots were used to evaluate the algorithm. Responsiveness (standardised response mean; SRM) of the mapped utilities was also investigated on a subset of participants with repeat assessments (N=85).Results There was a strong level of association between 8 items and 2 domains on the C19-YRSm with the EQ-5D single-item dimensions. These related to joint pain, muscle pain, anxiety, depression, walking/moving around, personal care, ADL, and social role, as well as Overall Health and Other Symptoms. Model fit was good (R2 = 0.7). The mean difference between the actual and mapped scores was < 0.10 for the range from 0 to 1 indicating a good degree of targeting for positive values of the EQ-5D-3L. The SRM for the mapped EQ-5D-3L health utilities (based on the C19-YRSm) was 0.37 compared to 0.17 for the observed EQ-5D-3L utility scores, suggesting the mapped EQ-5D-3L is more responsive to change.Conclusions We have developed a simple, responsive, and robust mapping algorithm to enable EQ-5D-3L health utilities to be generated from 10 items of the C19-YRSm. This mapping algorithm will facilitate economic evaluations of interventions, treatment, and management of people with LC, as well as further helping to describe and characterise patients with LC irrespective of any treatment and interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is independent research funded by the National Institute for Health and Care Research (NIHR) grant Ref COV-LT2-0016.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval for the LOCOMOTION study was obtained from the Bradford and Leeds Research Ethics Committee on behalf of Health Research Authority and Health and Care Research Wales (reference: 21/YH/0276).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.AICAkaike Information CriteriaC19-YRSmCovid 19 Yorkshire Rehabilitation Screening Tool (modified)CIConfidence IntervalEQ-5D-3LEuroQol 5-Dimension 3-LevelEQ-5D-5LEuroQol 5-Dimension 5-LevelFDFunctional Disability (from the C19-YRSm)HRQoLHealth-related Quality of LifeHTAHealth Technology AssessmentLCLong COVIDMAPSMApping onto Preference-based measures reporting StandardsNHSNational Health ServiceNICENational Institute for Health and Care ExcellenceOHOverall Health (from the C19-YRSm)OLSOrdinary Least SquaresOSOther Symptoms (from the C19-YRSm)PCSPost-COVID SyndromePROMPatient-reported Outcome MeasureRMSERoot Mean Squared ErrorSDStandard DeviationSEStandard ErrorSRMStandardised Response MeanSSSymptom Severity (from the C19-YRSm)VASVisual Analogue Scale